Efficacy of indefinite chronic oral antimicrobial suppression for prosthetic joint infection in the elderly: a comparative study

Affiliation auteurs!!!! Error affiliation !!!!
TitreEfficacy of indefinite chronic oral antimicrobial suppression for prosthetic joint infection in the elderly: a comparative study
Type de publicationJournal Article
Year of Publication2017
AuteursPrendki V., Sergent P., Barrelet A., Oziol E., Beretti E., Berlioz-Thibal M., Bouchand F., Dauchy F.A, Forestier E., Gavazzi G., Ronde-Oustau C., Stirnemann J., Dinh A.
JournalINTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
Volume60
Pagination57-60
Date PublishedJUL
Type of ArticleArticle
ISSN1201-9712
Mots-clésElderly, Prosthetic joint infection, Suppressive antimicrobial therapy
Résumé

Background: During prosthetic joint infection (PJI), surgical management is sometimes impossible and indefinite chronic oral antimicrobial suppression (ICOAS) may be the only option. The outcomes of elderly patients who benefited from ICOAS with strictly palliative intent were evaluated. Methods: A national retrospective cohort study was performed in France, involving patients aged > 75 years with a PJI who were managed with planned life-long ICOAS from 2009 to 2014. Patients who experienced an event were compared to those who did not. An event was defined as a composite outcome in patients undergoing ICOAS, including local or systemic progression of the infection, death, or discontinuation of antimicrobial therapy because of an adverse drug reaction. Results: Twenty-one patients were included, with a median age of 85 years (interquartile range 8188 years). Eight of the 21 patients experienced an event: one had an adverse drug reaction, three had systemic progression of sepsis, and two had local progression. Two of the 21 patients died. No death was related to ICOAS or infection. There was no significant difference between the population with an event and the population free of an event with regard to demographic, clinical, and microbiological characteristics (p > 0.05). Conclusions: ICOAS appeared to be an effective and safe option in this cohort. (C) 2017 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases. This is an open access article under the CC BY-NC-ND license

DOI10.1016/j.ijid.2017.05.008